Enterprise Value to EBITDA Multiple ratio Analysis of Royalty Pharma Plc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Indecisive EV to EBITDA
14.54
Period Ending - Dec-22
Very Poor EV to EBITDA
40.81
Growth
-64.36 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Not Good EV to EBITDA
18.98
EV to EBITDA Analysis of Royalty Pharma Plc
| EV to EBITDA Ratio of RPRX drastically fell by -64.36 % this year. |
| EV to EBITDA Ratio with value of 40.81 was highest in Year Dec-22 in last Five Years. |
| EV to EBITDA Ratio with value of 5.82 was lowest in Year Dec-19 in last Five Years. |
| Latest EV to EBITDA Ratio with value of 14.54 is lower than Average EV to EBITDA of 18.99 in last five years. |
Other EV to EBITDA Related Info of RPRX that may interest you.
Royalty Pharma Plc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| RPRX | 26.61 | 26.92 | 1.15 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| No Significant Value | |
FY - Historical Enterprise Value to EBITDA Multiple of Royalty Pharma Plc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | 14.54 | 40.81 | 20.45 | 13.35 | 5.82 | 8.29 | 0 |
| Change | -64.36 % | 99.58 % | 53.21 % | 129.21 % | -29.77 % | 0 % |
FY Chart of Enterprise Value to EBITDA Multiple of Royalty Pharma Plc
Note : All Data Generated at the End of Trading Hours (EOD Data)